top of page
News
Navigating the New EU Pharmacovigilance Regulation: What 2025/1466 Means for Strategic Oversight—And my thoughts on the UK Response
On 22 July 2025, the European Commission adopted the Implementing Regulation (EU) 2025/1466 , amending the long-standing...
Jul 242 min read
MHRA Scientific Advice: A Strategic Asset for Regulatory Success
In today’s fast-paced regulatory landscape, clarity is power. Whether you're developing a novel therapy, navigating post-Brexit...
Jul 222 min read
Valproate: Learning points for Marketing Authorisation Holders
The MHRA's findings on valproate highlight concerns regarding its use, particularly in relation to reproductive health and...
Jun 122 min read
Come and meet us next month
Dr Jackie Roberts reflects on going to conferences and conventions: “I have always loved attending conferences and having the chance to...
Apr 101 min read
IRP - The one benefit from Brexit?
International Recognition Procedures Jackie Roberts gives her thoughts on the International Recognition Procedure (IRP) and invites...
Feb 102 min read
bottom of page